These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1711377)

  • 1. Antibody conjugates with morpholinodoxorubicin and acid-cleavable linkers.
    Mueller BM; Wrasidlo WA; Reisfeld RA
    Bioconjug Chem; 1990; 1(5):325-30. PubMed ID: 1711377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New hydrazone derivatives of adriamycin and their immunoconjugates--a correlation between acid stability and cytotoxicity.
    Kaneko T; Willner D; Monkovíc I; Knipe JO; Braslawsky GR; Greenfield RS; Vyas DM
    Bioconjug Chem; 1991; 2(3):133-41. PubMed ID: 1932212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.
    Greenfield RS; Kaneko T; Daues A; Edson MA; Fitzgerald KA; Olech LJ; Grattan JA; Spitalny GL; Braslawsky GR
    Cancer Res; 1990 Oct; 50(20):6600-7. PubMed ID: 2208122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin.
    Willner D; Trail PA; Hofstead SJ; King HD; Lasch SJ; Braslawsky GR; Greenfield RS; Kaneko T; Firestone RA
    Bioconjug Chem; 1993; 4(6):521-7. PubMed ID: 7508268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugates.
    King HD; Yurgaitis D; Willner D; Firestone RA; Yang MB; Lasch SJ; Hellström KE; Trail PA
    Bioconjug Chem; 1999; 10(2):279-88. PubMed ID: 10077478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptide-based highly potent doxorubicin antibody conjugates.
    Jeffrey SC; Nguyen MT; Andreyka JB; Meyer DL; Doronina SO; Senter PD
    Bioorg Med Chem Lett; 2006 Jan; 16(2):358-62. PubMed ID: 16275070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methods.
    Sinkule JA; Rosen ST; Radosevich JA
    Tumour Biol; 1991; 12(4):198-206. PubMed ID: 1651554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity.
    Braslawsky GR; Kadow K; Knipe J; McGoff K; Edson M; Kaneko T; Greenfield RS
    Cancer Immunol Immunother; 1991; 33(6):367-74. PubMed ID: 1878890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models.
    Trail PA; Willner D; Lasch SJ; Henderson AJ; Greenfield RS; King D; Zoeckler ME; Braslawsky GR
    Cancer Res; 1992 Oct; 52(20):5693-700. PubMed ID: 1382845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced tumor cell selectivity of adriamycin-monoclonal antibody conjugate via a poly(ethylene glycol)-based cleavable linker.
    Suzawa T; Nagamura S; Saito H; Ohta S; Hanai N; Kanazawa J; Okabe M; Yamasaki M
    J Control Release; 2002 Feb; 79(1-3):229-42. PubMed ID: 11853934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of doxorubicin-monoclonal antibody conjugate on human bladder cancer.
    Yu DS; Chu TM; Yeh MY; Chang SY; Ma CP; Han SH
    J Urol; 1988 Aug; 140(2):415-21. PubMed ID: 3398165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide.
    Kerr DE; Senter PD; Burnett WV; Hirschberg DL; Hellström I; Hellström KE
    Cancer Immunol Immunother; 1990; 31(4):202-6. PubMed ID: 2116231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of a doxorubicin immunoconjugate in a preclinical model of spontaneous metastatic human melanoma.
    Sivam GP; Martin PJ; Reisfeld RA; Mueller BM
    Cancer Res; 1995 Jun; 55(11):2352-6. PubMed ID: 7757986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of methotrexate-antibody conjugates by regiospecific coupling and assessment of drug and antitumor activities.
    Kralovec J; Spencer G; Blair AH; Mammen M; Singh M; Ghose T
    J Med Chem; 1989 Nov; 32(11):2426-31. PubMed ID: 2810330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody conjugates of doxorubicin prepared with branched peptide linkers: inhibition of aggregation by methoxytriethyleneglycol chains.
    King HD; Dubowchik GM; Mastalerz H; Willner D; Hofstead SJ; Firestone RA; Lasch SJ; Trail PA
    J Med Chem; 2002 Sep; 45(19):4336-43. PubMed ID: 12213074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugation of the monoclonal antibody 17-1A with the nitroacridine compound C921 with the poly-L-lysine as an intermediate agent.
    Paprocka M; Boratyński J; Duś D; Kuśnierczyk H; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):343-9. PubMed ID: 9523011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved antitumor effects of 3'-deamino-3'-morpholino derivatives of pirarubicin.
    Ajito K; Ikeda D; Nosaka C; Komuro K; Kondo S; Takeuchi T
    J Antibiot (Tokyo); 1990 Nov; 43(11):1464-70. PubMed ID: 2272921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BR96 conjugates of highly potent anthracyclines.
    King HD; Staab AJ; Pham-Kaplita K; Yurgaitis D; Firestone RA; Lasch SJ; Trail PA
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2119-22. PubMed ID: 12798317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity.
    Ulbrich K; Etrych T; Chytil P; Jelínková M; Ríhová B
    J Control Release; 2003 Feb; 87(1-3):33-47. PubMed ID: 12618021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing.
    Braslawsky GR; Edson MA; Pearce W; Kaneko T; Greenfield RS
    Cancer Res; 1990 Oct; 50(20):6608-14. PubMed ID: 2208123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.